Subjective Study to Assess the Efficacy of APD125 in Patients With Sleep Maintenance Insomnia
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
This study is designed to compare 2 doses of APD125 (20 mg and 40 mg) with placebo in
otherwise healthy adults with primary insomnia primarily with complaints of maintaining
sleep. Participants will be required to maintain a daily sleep dairy for up to 3 weeks while
on study.